

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.93586666 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.93586666 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.93456790 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 6.04811675 |
| 5 | cellular response to interleukin-15 (GO:0071350) | 5.53844105 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.28845048 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.28845048 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.28845048 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.28845048 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.28845048 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 5.28845048 |
| 12 | response to interleukin-15 (GO:0070672) | 5.21740273 |
| 13 | tolerance induction (GO:0002507) | 4.98488712 |
| 14 | negative T cell selection (GO:0043383) | 4.88894108 |
| 15 | regulation of memory T cell differentiation (GO:0043380) | 4.81670402 |
| 16 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.74668781 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 4.73455802 |
| 18 | regulation of regulatory T cell differentiation (GO:0045589) | 4.68339315 |
| 19 | respiratory burst (GO:0045730) | 4.64926315 |
| 20 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.62279200 |
| 21 | response to peptidoglycan (GO:0032494) | 4.56313855 |
| 22 | negative thymic T cell selection (GO:0045060) | 4.52088074 |
| 23 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.48897902 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 4.39357969 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.36426270 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.36223405 |
| 27 | positive regulation of interferon-alpha production (GO:0032727) | 4.35212054 |
| 28 | negative regulation of T cell mediated immunity (GO:0002710) | 4.26232972 |
| 29 | regulation of interferon-alpha production (GO:0032647) | 4.20471287 |
| 30 | cytidine metabolic process (GO:0046087) | 4.15868098 |
| 31 | cytidine catabolic process (GO:0006216) | 4.15868098 |
| 32 | cytidine deamination (GO:0009972) | 4.15868098 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.14985348 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.12234881 |
| 35 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.11610117 |
| 36 | granulocyte activation (GO:0036230) | 4.08383232 |
| 37 | neutrophil activation (GO:0042119) | 4.04019142 |
| 38 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.03268956 |
| 39 | regulation of gamma-delta T cell activation (GO:0046643) | 4.02795661 |
| 40 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.97912709 |
| 41 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.97333871 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 3.94790013 |
| 43 | regulation of activation of Janus kinase activity (GO:0010533) | 3.91558666 |
| 44 | positive thymic T cell selection (GO:0045059) | 3.91299044 |
| 45 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.89911676 |
| 46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.86128340 |
| 47 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.85692181 |
| 48 | positive regulation of mast cell activation (GO:0033005) | 3.84455218 |
| 49 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.79126436 |
| 50 | dendritic cell chemotaxis (GO:0002407) | 3.78346679 |
| 51 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.76440164 |
| 52 | regulation of cell killing (GO:0031341) | 3.74464459 |
| 53 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.73447459 |
| 54 | positive T cell selection (GO:0043368) | 3.72759048 |
| 55 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.70795270 |
| 56 | eosinophil migration (GO:0072677) | 3.66703404 |
| 57 | activated T cell proliferation (GO:0050798) | 3.66676029 |
| 58 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.66538135 |
| 59 | positive regulation of mast cell degranulation (GO:0043306) | 3.64686204 |
| 60 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.64686204 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.62697182 |
| 62 | lymph node development (GO:0048535) | 3.61675271 |
| 63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.60572094 |
| 64 | defense response to protozoan (GO:0042832) | 3.59994351 |
| 65 | regulation of mast cell degranulation (GO:0043304) | 3.59694679 |
| 66 | myeloid dendritic cell activation (GO:0001773) | 3.58948844 |
| 67 | superoxide anion generation (GO:0042554) | 3.56379996 |
| 68 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.55989713 |
| 69 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.55662481 |
| 70 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.53820693 |
| 71 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.53820693 |
| 72 | response to host immune response (GO:0052572) | 3.53660410 |
| 73 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.53660410 |
| 74 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.53650162 |
| 75 | response to muramyl dipeptide (GO:0032495) | 3.53357752 |
| 76 | mast cell activation (GO:0045576) | 3.53098254 |
| 77 | regulation of mast cell activation (GO:0033003) | 3.52410513 |
| 78 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.51689016 |
| 79 | leukocyte aggregation (GO:0070486) | 3.49648429 |
| 80 | thymic T cell selection (GO:0045061) | 3.49538236 |
| 81 | DNA deamination (GO:0045006) | 3.49292628 |
| 82 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.48876815 |
| 83 | B cell mediated immunity (GO:0019724) | 3.48369087 |
| 84 | myeloid dendritic cell differentiation (GO:0043011) | 3.48090290 |
| 85 | positive regulation of antigen processing and presentation (GO:0002579) | 3.46181636 |
| 86 | regulation of chronic inflammatory response (GO:0002676) | 3.44865109 |
| 87 | T-helper cell differentiation (GO:0042093) | 3.44827045 |
| 88 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.44827045 |
| 89 | cellular response to interferon-beta (GO:0035458) | 3.44676569 |
| 90 | positive regulation of defense response to virus by host (GO:0002230) | 3.43494793 |
| 91 | negative regulation of T cell apoptotic process (GO:0070233) | 3.39574823 |
| 92 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.38465248 |
| 93 | reactive oxygen species biosynthetic process (GO:1903409) | 3.36941500 |
| 94 | regulation of T cell mediated immunity (GO:0002709) | 3.35575370 |
| 95 | T cell selection (GO:0045058) | 3.35487059 |
| 96 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.35241020 |
| 97 | positive regulation of cell killing (GO:0031343) | 3.34221019 |
| 98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.33728161 |
| 99 | positive regulation of B cell differentiation (GO:0045579) | 3.33676231 |
| 100 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.32746765 |
| 101 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.31503205 |
| 102 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.31503205 |
| 103 | dendritic cell migration (GO:0036336) | 3.29986004 |
| 104 | response to interferon-beta (GO:0035456) | 3.27000519 |
| 105 | macrophage activation (GO:0042116) | 3.26944301 |
| 106 | negative regulation of adaptive immune response (GO:0002820) | 3.26481494 |
| 107 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.26283736 |
| 108 | microglial cell activation (GO:0001774) | 3.26061424 |
| 109 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.26051521 |
| 110 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.25956952 |
| 111 | positive regulation of interferon-beta production (GO:0032728) | 3.24131252 |
| 112 | pinocytosis (GO:0006907) | 3.24108958 |
| 113 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.24077636 |
| 114 | response to protozoan (GO:0001562) | 3.22914103 |
| 115 | T cell migration (GO:0072678) | 3.22630089 |
| 116 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22173157 |
| 117 | positive regulation of T cell chemotaxis (GO:0010820) | 3.21768828 |
| 118 | regulation of T cell chemotaxis (GO:0010819) | 3.21768828 |
| 119 | cellular extravasation (GO:0045123) | 3.21111298 |
| 120 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.20261698 |
| 121 | cellular response to type I interferon (GO:0071357) | 3.19113723 |
| 122 | type I interferon signaling pathway (GO:0060337) | 3.19113723 |
| 123 | detection of molecule of bacterial origin (GO:0032490) | 3.18167750 |
| 124 | T cell differentiation involved in immune response (GO:0002292) | 3.17443157 |
| 125 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.17443157 |
| 126 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.17443157 |
| 127 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.17042044 |
| 128 | myeloid leukocyte activation (GO:0002274) | 3.16667761 |
| 129 | response to type I interferon (GO:0034340) | 3.16414517 |
| 130 | regulation of T cell tolerance induction (GO:0002664) | 3.16251885 |
| 131 | positive regulation of T cell mediated immunity (GO:0002711) | 3.14216522 |
| 132 | actin nucleation (GO:0045010) | 3.13219968 |
| 133 | negative regulation of interleukin-17 production (GO:0032700) | 3.12987072 |
| 134 | response to host (GO:0075136) | 3.11565256 |
| 135 | response to host defenses (GO:0052200) | 3.11565256 |
| 136 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11565256 |
| 137 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.11261807 |
| 138 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.11110802 |
| 139 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11068032 |
| 140 | regulation of B cell differentiation (GO:0045577) | 3.10347045 |
| 141 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.08984331 |
| 142 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.07823872 |
| 143 | regulation of germinal center formation (GO:0002634) | 3.07563431 |
| 144 | regulation of mononuclear cell migration (GO:0071675) | 3.07172037 |
| 145 | negative regulation of mast cell activation (GO:0033004) | 3.06081109 |
| 146 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.05779173 |
| 147 | interferon-gamma production (GO:0032609) | 3.04521625 |
| 148 | eosinophil chemotaxis (GO:0048245) | 3.04498341 |
| 149 | mast cell degranulation (GO:0043303) | 3.03952008 |
| 150 | mast cell activation involved in immune response (GO:0002279) | 3.03952008 |
| 151 | lymphocyte chemotaxis (GO:0048247) | 3.02616877 |
| 152 | T cell costimulation (GO:0031295) | 3.01807185 |
| 153 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.01013061 |
| 154 | T cell receptor signaling pathway (GO:0050852) | 3.00004585 |
| 155 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.99197298 |
| 156 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.98741937 |
| 157 | regulation of monocyte chemotaxis (GO:0090025) | 2.98320867 |
| 158 | regulation of leukocyte degranulation (GO:0043300) | 2.98219769 |
| 159 | natural killer cell mediated immunity (GO:0002228) | 2.98116162 |
| 160 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.98116162 |
| 161 | positive regulation of granulocyte differentiation (GO:0030854) | 2.98051142 |
| 162 | lymphocyte costimulation (GO:0031294) | 2.97515353 |
| 163 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.96319656 |
| 164 | dendritic cell differentiation (GO:0097028) | 2.95336693 |
| 165 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.94335902 |
| 166 | cellular response to exogenous dsRNA (GO:0071360) | 2.92112810 |
| 167 | T-helper 1 type immune response (GO:0042088) | 2.92017792 |
| 168 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.91699670 |
| 169 | regulation of antigen processing and presentation (GO:0002577) | 2.91490830 |
| 170 | positive regulation of interleukin-4 production (GO:0032753) | 2.91152168 |
| 171 | leukocyte mediated cytotoxicity (GO:0001909) | 2.90786926 |
| 172 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.90636252 |
| 173 | negative regulation of innate immune response (GO:0045824) | 2.88960687 |
| 174 | regulation of tolerance induction (GO:0002643) | 2.88703968 |
| 175 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88079236 |
| 176 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.87597801 |
| 177 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.87455012 |
| 178 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.87312192 |
| 179 | regulation of chemokine biosynthetic process (GO:0045073) | 2.87136068 |
| 180 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.86463039 |
| 181 | neutrophil mediated immunity (GO:0002446) | 2.86395429 |
| 182 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.86143422 |
| 183 | positive regulation of interleukin-10 production (GO:0032733) | 2.84032846 |
| 184 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.83757470 |
| 185 | mitotic cell cycle arrest (GO:0071850) | 2.82065420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.47039187 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.59398673 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.56538463 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.37959207 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.17368784 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.12204448 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.80705575 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.75907358 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.72968384 |
| 10 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.58223807 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.55547914 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.20034155 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.12630479 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.87431530 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82898592 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.67095740 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61177646 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.57845861 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40204888 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40062699 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38674955 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35238575 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.24884659 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.20073042 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.08628879 |
| 26 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.02304904 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.97807203 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94189800 |
| 29 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.87351560 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83616646 |
| 31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.82417244 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82368661 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.81789934 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79658722 |
| 35 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.79491744 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.79049727 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78481273 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74156961 |
| 39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.72560058 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66611930 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.64956809 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63198871 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59102015 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.54763214 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.53104860 |
| 46 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.52692117 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51862917 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.46736476 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44065731 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.43262073 |
| 51 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43239010 |
| 52 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35464859 |
| 53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.34738055 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33739250 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31480967 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30049910 |
| 57 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29570331 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27969619 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25276194 |
| 60 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24343260 |
| 61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23168626 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21123681 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20694926 |
| 64 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.16918832 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16490463 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12772651 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10494778 |
| 68 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09001313 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07958959 |
| 70 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07358969 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06872328 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02081219 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.01409380 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01236218 |
| 75 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00303383 |
| 76 | GATA3_26560356_Chip-Seq_TH1_Human | 0.98566741 |
| 77 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98115949 |
| 78 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97608327 |
| 79 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97540325 |
| 80 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97130482 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95932262 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95209180 |
| 83 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92502505 |
| 84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92305125 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91503955 |
| 86 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90432347 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86975559 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.86437852 |
| 89 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.84160355 |
| 90 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84088224 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83826767 |
| 92 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.83335435 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 0.82493608 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82307963 |
| 95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81702289 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78659496 |
| 97 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.76632920 |
| 98 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76467796 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76110501 |
| 100 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.74954592 |
| 101 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.73578653 |
| 102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.72744257 |
| 103 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.72017265 |
| 104 | P300_27268052_Chip-Seq_Bcells_Human | 0.71989201 |
| 105 | MYC_22102868_ChIP-Seq_BL_Human | 0.71678385 |
| 106 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.71124107 |
| 107 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.70078094 |
| 108 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69996992 |
| 109 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.69421301 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69181838 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68539992 |
| 112 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67855685 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67582292 |
| 114 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.67366400 |
| 115 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.66681221 |
| 116 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.66646959 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.64394019 |
| 118 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63591432 |
| 119 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.63433908 |
| 120 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62099963 |
| 121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61063565 |
| 122 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.60598851 |
| 123 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.60158953 |
| 124 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.59895637 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58370813 |
| 126 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58370813 |
| 127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.56039729 |
| 128 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.55790903 |
| 129 | GATA1_19941826_ChIP-Seq_K562_Human | 0.55658727 |
| 130 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.55307940 |
| 131 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.54144115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.90444407 |
| 2 | MP0003436_decreased_susceptibility_to | 4.13172634 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.74774931 |
| 4 | MP0009785_altered_susceptibility_to | 3.69647564 |
| 5 | MP0006082_CNS_inflammation | 3.41628080 |
| 6 | MP0002419_abnormal_innate_immunity | 3.35705212 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.33761823 |
| 8 | MP0003303_peritoneal_inflammation | 3.14497705 |
| 9 | MP0005025_abnormal_response_to | 3.11945374 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.99129386 |
| 11 | * MP0005671_abnormal_response_to | 2.82445201 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.76832327 |
| 13 | MP0003724_increased_susceptibility_to | 2.73156873 |
| 14 | MP0000685_abnormal_immune_system | 2.66153780 |
| 15 | * MP0002723_abnormal_immune_serum | 2.61319337 |
| 16 | MP0001800_abnormal_humoral_immune | 2.61278036 |
| 17 | MP0005387_immune_system_phenotype | 2.58301048 |
| 18 | MP0001790_abnormal_immune_system | 2.58301048 |
| 19 | MP0002009_preneoplasia | 2.50596559 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.49537188 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.42081991 |
| 22 | * MP0001819_abnormal_immune_cell | 2.41496852 |
| 23 | MP0001853_heart_inflammation | 2.20299822 |
| 24 | MP0004510_myositis | 2.18216877 |
| 25 | MP0002405_respiratory_system_inflammati | 2.15028165 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.06679315 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.97120283 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.95563651 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.82744772 |
| 30 | MP0009764_decreased_sensitivity_to | 1.82682328 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.80465936 |
| 32 | MP0000716_abnormal_immune_system | 1.77445170 |
| 33 | MP0000343_altered_response_to | 1.77261799 |
| 34 | MP0002398_abnormal_bone_marrow | 1.72456203 |
| 35 | MP0005174_abnormal_tail_pigmentation | 1.70876680 |
| 36 | MP0003075_altered_response_to | 1.69959680 |
| 37 | MP0003448_altered_tumor_morphology | 1.69319727 |
| 38 | MP0008469_abnormal_protein_level | 1.68610341 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.62476764 |
| 40 | MP0004947_skin_inflammation | 1.61419113 |
| 41 | MP0005310_abnormal_salivary_gland | 1.60604635 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.51692255 |
| 43 | MP0005166_decreased_susceptibility_to | 1.49280941 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.49093143 |
| 45 | MP0004381_abnormal_hair_follicle | 1.48942165 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.47188723 |
| 47 | MP0009840_abnormal_foam_cell | 1.46437715 |
| 48 | MP0000858_altered_metastatic_potential | 1.44399229 |
| 49 | MP0002429_abnormal_blood_cell | 1.43798428 |
| 50 | MP0003690_abnormal_glial_cell | 1.40273715 |
| 51 | MP0002006_tumorigenesis | 1.39463298 |
| 52 | MP0002722_abnormal_immune_system | 1.37788700 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.29979148 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.26763197 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.26544809 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.26544809 |
| 57 | MP0000604_amyloidosis | 1.25968823 |
| 58 | MP0003828_pulmonary_edema | 1.19768055 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.17072370 |
| 60 | MP0001851_eye_inflammation | 1.14371743 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.13694509 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.09427712 |
| 63 | MP0002933_joint_inflammation | 1.09364330 |
| 64 | MP0002166_altered_tumor_susceptibility | 1.07383347 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.00081922 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 0.99951320 |
| 67 | MP0009278_abnormal_bone_marrow | 0.99593014 |
| 68 | MP0009763_increased_sensitivity_to | 0.96266396 |
| 69 | MP0002396_abnormal_hematopoietic_system | 0.95580869 |
| 70 | MP0003866_abnormal_defecation | 0.94658064 |
| 71 | MP0002876_abnormal_thyroid_physiology | 0.93119290 |
| 72 | MP0010307_abnormal_tumor_latency | 0.93083239 |
| 73 | MP0005390_skeleton_phenotype | 0.92469158 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 0.92468596 |
| 75 | MP0001873_stomach_inflammation | 0.91161076 |
| 76 | MP0000490_abnormal_crypts_of | 0.90065613 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.90034678 |
| 78 | MP0003878_abnormal_ear_physiology | 0.89837200 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 0.89837200 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.89581921 |
| 81 | MP0001501_abnormal_sleep_pattern | 0.89143540 |
| 82 | MP0003186_abnormal_redox_activity | 0.87485428 |
| 83 | MP0000249_abnormal_blood_vessel | 0.86745684 |
| 84 | MP0001919_abnormal_reproductive_system | 0.85655556 |
| 85 | MP0004130_abnormal_muscle_cell | 0.84315055 |
| 86 | MP0005164_abnormal_response_to | 0.81909667 |
| 87 | MP0000371_diluted_coat_color | 0.80274782 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.78958141 |
| 89 | MP0004147_increased_porphyrin_level | 0.78442870 |
| 90 | MP0003045_fibrosis | 0.78090208 |
| 91 | MP0003795_abnormal_bone_structure | 0.77912138 |
| 92 | MP0008260_abnormal_autophagy | 0.76376927 |
| 93 | MP0003806_abnormal_nucleotide_metabolis | 0.75984223 |
| 94 | MP0000703_abnormal_thymus_morphology | 0.74788069 |
| 95 | MP0001663_abnormal_digestive_system | 0.72763796 |
| 96 | MP0001765_abnormal_ion_homeostasis | 0.72050672 |
| 97 | MP0004883_abnormal_blood_vessel | 0.70280496 |
| 98 | MP0002102_abnormal_ear_morphology | 0.70277278 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.70039116 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.67814174 |
| 101 | MP0006054_spinal_hemorrhage | 0.66988539 |
| 102 | MP0004264_abnormal_extraembryonic_tissu | 0.66748547 |
| 103 | MP0000920_abnormal_myelination | 0.63453237 |
| 104 | MP0002254_reproductive_system_inflammat | 0.61872683 |
| 105 | MP0002132_abnormal_respiratory_system | 0.60823821 |
| 106 | MP0005647_abnormal_sex_gland | 0.59751883 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.59558266 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.58744603 |
| 109 | MP0002139_abnormal_hepatobiliary_system | 0.58528700 |
| 110 | MP0000372_irregular_coat_pigmentation | 0.58399112 |
| 111 | MP0008873_increased_physiological_sensi | 0.58357058 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.57231887 |
| 113 | MP0010329_abnormal_lipoprotein_level | 0.56462942 |
| 114 | MP0003011_delayed_dark_adaptation | 0.56228668 |
| 115 | MP0005075_abnormal_melanosome_morpholog | 0.54770792 |
| 116 | MP0002095_abnormal_skin_pigmentation | 0.53996145 |
| 117 | MP0008877_abnormal_DNA_methylation | 0.53725491 |
| 118 | MP0003279_aneurysm | 0.51316103 |
| 119 | MP0010386_abnormal_urinary_bladder | 0.51193592 |
| 120 | MP0010352_gastrointestinal_tract_polyps | 0.48815483 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.46432631 |
| 122 | MP0002019_abnormal_tumor_incidence | 0.46215097 |
| 123 | MP0005076_abnormal_cell_differentiation | 0.44736977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.71331363 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 7.17902151 |
| 3 | Eczematoid dermatitis (HP:0000976) | 7.12441006 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.24437901 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.37761140 |
| 6 | IgG deficiency (HP:0004315) | 5.34646933 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.14160659 |
| 8 | Myositis (HP:0100614) | 4.58717263 |
| 9 | Recurrent skin infections (HP:0001581) | 4.57906559 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.53886035 |
| 11 | Severe combined immunodeficiency (HP:0004430) | 4.35290985 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 4.33584812 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.23118523 |
| 14 | Orchitis (HP:0100796) | 4.22036811 |
| 15 | Stomach cancer (HP:0012126) | 4.13209964 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.10632574 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 4.09051529 |
| 18 | Optic neuritis (HP:0100653) | 4.09051529 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.07548001 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 4.05641600 |
| 21 | Obstructive lung disease (HP:0006536) | 4.05641600 |
| 22 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.01383038 |
| 23 | Gingivitis (HP:0000230) | 3.92262826 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.91157361 |
| 25 | Disinhibition (HP:0000734) | 3.83255966 |
| 26 | Agnosia (HP:0010524) | 3.81572270 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 3.78966309 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.52578182 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.49485614 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.49485614 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.49485614 |
| 32 | Combined immunodeficiency (HP:0005387) | 3.47467027 |
| 33 | Prostate neoplasm (HP:0100787) | 3.35078567 |
| 34 | Axonal loss (HP:0003447) | 3.33985292 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 3.31702028 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.28640596 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 3.28640596 |
| 38 | Recurrent bronchitis (HP:0002837) | 3.27590143 |
| 39 | Stomatitis (HP:0010280) | 3.26783911 |
| 40 | Chronic diarrhea (HP:0002028) | 3.20814977 |
| 41 | Recurrent viral infections (HP:0004429) | 3.20364013 |
| 42 | Dysostosis multiplex (HP:0000943) | 3.15564431 |
| 43 | Cellulitis (HP:0100658) | 3.06000851 |
| 44 | Abnormality of B cell number (HP:0010975) | 3.04535495 |
| 45 | Vasculitis (HP:0002633) | 3.02888030 |
| 46 | Petechiae (HP:0000967) | 3.00689736 |
| 47 | Granulocytopenia (HP:0001913) | 2.88611856 |
| 48 | Meningitis (HP:0001287) | 2.84903257 |
| 49 | Basal ganglia calcification (HP:0002135) | 2.82394325 |
| 50 | Glomerulonephritis (HP:0000099) | 2.77867135 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.74777023 |
| 52 | Urticaria (HP:0001025) | 2.72057073 |
| 53 | Periodontitis (HP:0000704) | 2.71832576 |
| 54 | Hepatosplenomegaly (HP:0001433) | 2.71524529 |
| 55 | Abnormality of the prostate (HP:0008775) | 2.70501687 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.68007476 |
| 57 | Arterial thrombosis (HP:0004420) | 2.65177039 |
| 58 | Pustule (HP:0200039) | 2.64196604 |
| 59 | Abnormality of male internal genitalia (HP:0000022) | 2.58707281 |
| 60 | Leukocytosis (HP:0001974) | 2.56645469 |
| 61 | Keratoconjunctivitis sicca (HP:0001097) | 2.55507575 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.53175075 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.53175075 |
| 64 | Recurrent pneumonia (HP:0006532) | 2.51314347 |
| 65 | Hemoptysis (HP:0002105) | 2.50367413 |
| 66 | Pulmonary embolism (HP:0002204) | 2.48730187 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 2.47589890 |
| 68 | B lymphocytopenia (HP:0010976) | 2.45099409 |
| 69 | Osteomyelitis (HP:0002754) | 2.42834380 |
| 70 | Pulmonary fibrosis (HP:0002206) | 2.42371019 |
| 71 | Glomerulopathy (HP:0100820) | 2.39652841 |
| 72 | Gingival bleeding (HP:0000225) | 2.37415036 |
| 73 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.36255831 |
| 74 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.36255831 |
| 75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.36255831 |
| 76 | Conical tooth (HP:0000698) | 2.35418998 |
| 77 | Anhidrosis (HP:0000970) | 2.34172088 |
| 78 | IgA deficiency (HP:0002720) | 2.31822891 |
| 79 | Chest pain (HP:0100749) | 2.31767538 |
| 80 | Keratoconjunctivitis (HP:0001096) | 2.30471456 |
| 81 | Epistaxis (HP:0000421) | 2.28164264 |
| 82 | Upper motor neuron abnormality (HP:0002127) | 2.28054758 |
| 83 | Prolonged bleeding time (HP:0003010) | 2.27798756 |
| 84 | Poor head control (HP:0002421) | 2.27686259 |
| 85 | Joint swelling (HP:0001386) | 2.26716154 |
| 86 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26616566 |
| 87 | Thrombocytosis (HP:0001894) | 2.25291101 |
| 88 | IgM deficiency (HP:0002850) | 2.24605801 |
| 89 | Albinism (HP:0001022) | 2.22544348 |
| 90 | Thick nail (HP:0001805) | 2.22280817 |
| 91 | Panhypogammaglobulinemia (HP:0003139) | 2.20155119 |
| 92 | Myocardial infarction (HP:0001658) | 2.17982139 |
| 93 | Joint hemorrhage (HP:0005261) | 2.17021177 |
| 94 | Recurrent lower respiratory tract infections (HP:0002783) | 2.15764976 |
| 95 | Renal cortical cysts (HP:0000803) | 2.14512493 |
| 96 | Loss of speech (HP:0002371) | 2.13366597 |
| 97 | Inflammation of the large intestine (HP:0002037) | 2.10283181 |
| 98 | Spinal cord lesions (HP:0100561) | 2.08987899 |
| 99 | Syringomyelia (HP:0003396) | 2.08987899 |
| 100 | Anorexia (HP:0002039) | 2.08505719 |
| 101 | Abnormality of T cell number (HP:0011839) | 2.04383336 |
| 102 | Chronic otitis media (HP:0000389) | 2.03706751 |
| 103 | Purpura (HP:0000979) | 2.02304138 |
| 104 | Bronchitis (HP:0012387) | 2.01287791 |
| 105 | Increased IgM level (HP:0003496) | 2.00523676 |
| 106 | Thyroiditis (HP:0100646) | 1.98911097 |
| 107 | Spontaneous hematomas (HP:0007420) | 1.98539879 |
| 108 | Lymphopenia (HP:0001888) | 1.97785213 |
| 109 | Hypergammaglobulinemia (HP:0010702) | 1.97613898 |
| 110 | Keratitis (HP:0000491) | 1.97468100 |
| 111 | Diminished motivation (HP:0000745) | 1.97166208 |
| 112 | T lymphocytopenia (HP:0005403) | 1.96429815 |
| 113 | Metaphyseal dysplasia (HP:0100255) | 1.95993003 |
| 114 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95188376 |
| 115 | Inappropriate behavior (HP:0000719) | 1.94835805 |
| 116 | Gastrointestinal inflammation (HP:0004386) | 1.94283181 |
| 117 | Vertigo (HP:0002321) | 1.93933638 |
| 118 | Porencephaly (HP:0002132) | 1.93236752 |
| 119 | Abnormality of the pleura (HP:0002103) | 1.93094946 |
| 120 | Hematochezia (HP:0002573) | 1.92326679 |
| 121 | Sepsis (HP:0100806) | 1.92109799 |
| 122 | Beaking of vertebral bodies (HP:0004568) | 1.91608271 |
| 123 | Agammaglobulinemia (HP:0004432) | 1.90487552 |
| 124 | Gastrointestinal infarctions (HP:0005244) | 1.90103168 |
| 125 | Gangrene (HP:0100758) | 1.88982535 |
| 126 | Cheilitis (HP:0100825) | 1.88809303 |
| 127 | Eosinophilia (HP:0001880) | 1.88348067 |
| 128 | Encephalitis (HP:0002383) | 1.88074463 |
| 129 | Methylmalonic acidemia (HP:0002912) | 1.87540004 |
| 130 | Spondylolisthesis (HP:0003302) | 1.85927638 |
| 131 | Personality changes (HP:0000751) | 1.85589820 |
| 132 | Gastrointestinal stroma tumor (HP:0100723) | 1.85411876 |
| 133 | Abnormality of the pericardium (HP:0001697) | 1.84390256 |
| 134 | Nephritis (HP:0000123) | 1.83751759 |
| 135 | Arthralgia (HP:0002829) | 1.83461329 |
| 136 | Polyneuropathy (HP:0001271) | 1.83213521 |
| 137 | Abnormality of T cells (HP:0002843) | 1.82759521 |
| 138 | Recurrent sinusitis (HP:0011108) | 1.82572892 |
| 139 | Growth hormone excess (HP:0000845) | 1.82261353 |
| 140 | Abnormality of eosinophils (HP:0001879) | 1.82041920 |
| 141 | Pancreatitis (HP:0001733) | 1.81709819 |
| 142 | Neutropenia (HP:0001875) | 1.77776479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.35995547 |
| 2 | BLK | 4.21417333 |
| 3 | MAP3K14 | 3.77038582 |
| 4 | MAP4K1 | 3.52916489 |
| 5 | TXK | 3.35618391 |
| 6 | IRAK3 | 3.11501874 |
| 7 | TBK1 | 3.09653986 |
| 8 | MAP2K2 | 3.01524349 |
| 9 | IRAK4 | 2.94999301 |
| 10 | TYK2 | 2.83800400 |
| 11 | KIT | 2.81532260 |
| 12 | TESK2 | 2.57066737 |
| 13 | JAK3 | 2.34785584 |
| 14 | IKBKB | 2.30655509 |
| 15 | PBK | 2.27445245 |
| 16 | MAP3K9 | 2.23692736 |
| 17 | NME2 | 2.12513765 |
| 18 | PIM2 | 2.03023150 |
| 19 | IKBKE | 1.99088178 |
| 20 | ZAP70 | 1.91935081 |
| 21 | TEC | 1.81194029 |
| 22 | BTK | 1.79636816 |
| 23 | SYK | 1.74741209 |
| 24 | JAK1 | 1.74032875 |
| 25 | CSF1R | 1.66571616 |
| 26 | ERN1 | 1.59785527 |
| 27 | TLK1 | 1.58077827 |
| 28 | NEK9 | 1.54584404 |
| 29 | TAOK3 | 1.49888159 |
| 30 | TGFBR2 | 1.47952026 |
| 31 | HCK | 1.42949174 |
| 32 | LYN | 1.41093492 |
| 33 | CLK1 | 1.39872872 |
| 34 | LCK | 1.35252133 |
| 35 | CSK | 1.30473767 |
| 36 | STK10 | 1.25973281 |
| 37 | FES | 1.20719924 |
| 38 | MATK | 1.20698709 |
| 39 | JAK2 | 1.20456117 |
| 40 | MAP4K2 | 1.17875030 |
| 41 | FGR | 1.17393082 |
| 42 | ABL2 | 1.16339452 |
| 43 | PIM1 | 1.15449180 |
| 44 | CHUK | 1.12892025 |
| 45 | GRK7 | 1.12535828 |
| 46 | BMPR2 | 1.10898214 |
| 47 | ITK | 1.04384901 |
| 48 | MAP2K3 | 1.04224615 |
| 49 | MAP3K13 | 1.01328508 |
| 50 | MAPK7 | 0.91373066 |
| 51 | ARAF | 0.89555970 |
| 52 | TRPM7 | 0.87033891 |
| 53 | BMX | 0.85901542 |
| 54 | EPHB1 | 0.85547699 |
| 55 | ADRBK2 | 0.84306840 |
| 56 | YES1 | 0.84217832 |
| 57 | MAP3K12 | 0.82641660 |
| 58 | ZAK | 0.79780849 |
| 59 | MARK3 | 0.79725753 |
| 60 | MST4 | 0.76652781 |
| 61 | STK4 | 0.76437806 |
| 62 | RPS6KA4 | 0.74338032 |
| 63 | PRKCD | 0.73218121 |
| 64 | MAP2K1 | 0.70159810 |
| 65 | GRK1 | 0.66352425 |
| 66 | FGFR3 | 0.65731528 |
| 67 | EIF2AK2 | 0.65110594 |
| 68 | ABL1 | 0.63043076 |
| 69 | SIK3 | 0.63033476 |
| 70 | ERBB3 | 0.61860209 |
| 71 | BMPR1B | 0.61455027 |
| 72 | FLT3 | 0.60517036 |
| 73 | PIK3CA | 0.60133133 |
| 74 | LRRK2 | 0.59330815 |
| 75 | SCYL2 | 0.59001846 |
| 76 | RAF1 | 0.56178702 |
| 77 | PINK1 | 0.55977608 |
| 78 | BCKDK | 0.54842919 |
| 79 | CDK6 | 0.54743928 |
| 80 | EPHA3 | 0.54613081 |
| 81 | KSR2 | 0.54409347 |
| 82 | FRK | 0.53658499 |
| 83 | SIK2 | 0.52749628 |
| 84 | EGFR | 0.52457693 |
| 85 | PTK2B | 0.52312245 |
| 86 | PDK1 | 0.46366376 |
| 87 | PRKCQ | 0.46064186 |
| 88 | ACVR1B | 0.45979562 |
| 89 | MAP3K11 | 0.45116153 |
| 90 | IRAK1 | 0.44728813 |
| 91 | FGFR4 | 0.44245020 |
| 92 | DYRK3 | 0.43796464 |
| 93 | MAPKAPK2 | 0.43366254 |
| 94 | TGFBR1 | 0.41259527 |
| 95 | ERBB2 | 0.40974763 |
| 96 | DAPK2 | 0.40768977 |
| 97 | MAP3K5 | 0.40220222 |
| 98 | MAP3K10 | 0.40130925 |
| 99 | GRK6 | 0.39824315 |
| 100 | RIPK1 | 0.39404392 |
| 101 | RPS6KA6 | 0.38270613 |
| 102 | FYN | 0.37321075 |
| 103 | NUAK1 | 0.37225884 |
| 104 | PIK3CG | 0.35783088 |
| 105 | RPS6KA2 | 0.33718876 |
| 106 | CAMKK2 | 0.31429455 |
| 107 | PDGFRB | 0.31376034 |
| 108 | IGF1R | 0.31320348 |
| 109 | NLK | 0.29568189 |
| 110 | MOS | 0.29005040 |
| 111 | MAP2K6 | 0.28621201 |
| 112 | INSR | 0.28059857 |
| 113 | HIPK2 | 0.26317166 |
| 114 | PDPK1 | 0.26230989 |
| 115 | MAPK12 | 0.25910162 |
| 116 | GRK5 | 0.25433068 |
| 117 | RPS6KL1 | 0.25350853 |
| 118 | RPS6KC1 | 0.25350853 |
| 119 | IRAK2 | 0.25108504 |
| 120 | MAPK4 | 0.25102777 |
| 121 | PRKG2 | 0.24718282 |
| 122 | PKN2 | 0.24670827 |
| 123 | CDK4 | 0.24544269 |
| 124 | TAOK2 | 0.24390208 |
| 125 | MAPKAPK3 | 0.23207699 |
| 126 | ADRBK1 | 0.23099294 |
| 127 | TNK2 | 0.22600118 |
| 128 | MAPK11 | 0.21424280 |
| 129 | MST1R | 0.20177639 |
| 130 | DYRK1B | 0.19983701 |
| 131 | KDR | 0.19876258 |
| 132 | MAP3K1 | 0.19363712 |
| 133 | MAPK3 | 0.18030764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.48465153 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.17475057 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.00208128 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51005561 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.50987929 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.49406202 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.45290886 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.45015593 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.44198083 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.42592868 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.40959575 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37344342 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.35384129 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.30535420 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 2.30366831 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.08833691 |
| 17 | Malaria_Homo sapiens_hsa05144 | 2.08576896 |
| 18 | Measles_Homo sapiens_hsa05162 | 2.08242715 |
| 19 | Phagosome_Homo sapiens_hsa04145 | 2.07048766 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 2.02313229 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.92065452 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.92047057 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.91147879 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.82488773 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80960529 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.78827209 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65336489 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.54249508 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.53738929 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53219212 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.49811736 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47737504 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47120009 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47002235 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45629311 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38772520 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38417948 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34288094 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33437532 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.32708104 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.29802479 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.29418106 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23321510 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22311863 |
| 45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.20645721 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11943844 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07998186 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06688972 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05150888 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04683630 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03379328 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02898227 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 1.00161066 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92322932 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89253634 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88527610 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85728445 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.85217525 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.84498364 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80280931 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79667085 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79588919 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77831793 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71965999 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.69893075 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67903152 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61359526 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61241159 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58800373 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56308744 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55979733 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51938348 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51756111 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51074907 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49742761 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47384510 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47349727 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46735576 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46298207 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.46162647 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45125681 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40530759 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39657566 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.38855146 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38829622 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37763287 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37424337 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35628177 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34451458 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34167387 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.32748024 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31341372 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31180985 |
| 94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28643243 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.28154258 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26991099 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.23575574 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23445864 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23016261 |
| 100 | Phototransduction_Homo sapiens_hsa04744 | 0.22930911 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21673953 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21471325 |
| 103 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.20695800 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17107018 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16989856 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.14434230 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.13992925 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.13365384 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11904769 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.11465029 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.11453920 |
| 112 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.11425936 |
| 113 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.10155247 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.09180192 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09064239 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.08762145 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.06565459 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.06214542 |
| 119 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.06182156 |
| 120 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.06154648 |
| 121 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.05136927 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.04587345 |
| 123 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.03726184 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.02868792 |
| 125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.02357780 |

